Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Polman

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Neurology|January 15, 2003
Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1bC Polman, L Kappos, R White, et al.
Journal of Science and Medicine in Sport|February 29, 2016
Light physical activity is positively associated with cognitive performance in older community dwelling adultsLiam G Johnson, Michael L Butson, Remco C Polman, et al.
European Journal of Neurology|October 26, 2005
Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosisP S Sørensen, F Deisenhammer, P Duda, et al.
AJNR. American Journal of Neuroradiology|March 21, 1998
Sagittal MR of multiple sclerosis in the spinal cord: fast versus conventional spin-echo imagingG J Lycklama à Nijeholt, J A Castelijns, J Weerts, et al.
Neurology|November 28, 2001
Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of lifeJ A Freeman, A J Thompson, R Fitzpatrick, et al.
Journal of Neurology|May 17, 2005
Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosisPeter Rieckmann, N Kruse, L Nagelkerken, et al.
Neurology|May 6, 2011
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosisP W O'Connor, A Goodman, L Kappos, et al.
European Neurology|August 7, 1998
Patterns of brain magnetic resonance abnormalities on T2-weighted spin echo images in clinical subgroups of multiple sclerosis: a large cross-sectional studyM A van Walderveen, F Barkhof, M W Tas, et al.
AJNR. American Journal of Neuroradiology|June 1, 1997
MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disabilityG J Lycklama à Nijeholt, F Barkhof, P Scheltens, et al.
Journal of Vascular Surgery|September 22, 2010
Hull early walking aid for rehabilitation of transtibial amputees--randomized controlled trial (HEART)Fayyaz Ali Khan Mazari, Katherine Mockford, Cleveland Barnett, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Neurology|January 15, 2003
Neutralizing antibodies during treatment of secondary progressive MS with interferon beta-1bC Polman, L Kappos, R White, et al.
Journal of Science and Medicine in Sport|February 29, 2016
Light physical activity is positively associated with cognitive performance in older community dwelling adultsLiam G Johnson, Michael L Butson, Remco C Polman, et al.
European Journal of Neurology|October 26, 2005
Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosisP S Sørensen, F Deisenhammer, P Duda, et al.
AJNR. American Journal of Neuroradiology|March 21, 1998
Sagittal MR of multiple sclerosis in the spinal cord: fast versus conventional spin-echo imagingG J Lycklama à Nijeholt, J A Castelijns, J Weerts, et al.
Neurology|November 28, 2001
Interferon-beta1b in the treatment of secondary progressive MS: impact on quality of lifeJ A Freeman, A J Thompson, R Fitzpatrick, et al.
Journal of Neurology|May 17, 2005
Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosisPeter Rieckmann, N Kruse, L Nagelkerken, et al.
Neurology|May 6, 2011
Disease activity return during natalizumab treatment interruption in patients with multiple sclerosisP W O'Connor, A Goodman, L Kappos, et al.
European Neurology|August 7, 1998
Patterns of brain magnetic resonance abnormalities on T2-weighted spin echo images in clinical subgroups of multiple sclerosis: a large cross-sectional studyM A van Walderveen, F Barkhof, M W Tas, et al.
AJNR. American Journal of Neuroradiology|June 1, 1997
MR of the spinal cord in multiple sclerosis: relation to clinical subtype and disabilityG J Lycklama à Nijeholt, F Barkhof, P Scheltens, et al.
Journal of Vascular Surgery|September 22, 2010
Hull early walking aid for rehabilitation of transtibial amputees--randomized controlled trial (HEART)Fayyaz Ali Khan Mazari, Katherine Mockford, Cleveland Barnett, et al.
Pageof 5